T. Rowe Price Associates’s Intermolecular, Inc. IMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-156,015
Closed -$158K 2577
2018
Q4
$158K Buy
+156,015
New +$157K ﹤0.01% 2444
2018
Q1
Sell
-147,502
Closed -$202K 2607
2017
Q4
$202K Sell
147,502
-481,608
-77% -$580K ﹤0.01% 2422
2017
Q3
$642K Sell
629,110
-8,634
-1% -$8.13K ﹤0.01% 1991
2017
Q2
$593K Sell
637,744
-11,200
-2% -$9.79K ﹤0.01% 1989
2017
Q1
$604K Sell
648,944
-25,256
-4% -$26.4K ﹤0.01% 1984
2016
Q4
$639K Hold
674,200
﹤0.01% 1955
2016
Q3
$669K Hold
674,200
﹤0.01% 1899
2016
Q2
$998K Buy
674,200
+11,200
+2% +$22.6K ﹤0.01% 1709
2016
Q1
$1.68M Hold
663,000
﹤0.01% 1562
2015
Q4
$1.54M Hold
663,000
﹤0.01% 1584
2015
Q3
$1.25M Hold
663,000
﹤0.01% 1647
2015
Q2
$1.31M Hold
663,000
﹤0.01% 1671
2015
Q1
$1.09M Hold
663,000
﹤0.01% 1707
2014
Q4
$1.28M Hold
663,000
﹤0.01% 1664
2014
Q3
$1.54M Hold
663,000
﹤0.01% 1620
2014
Q2
$1.54M Hold
663,000
﹤0.01% 1627
2014
Q1
$1.86M Buy
663,000
+221,000
+50% +$805K ﹤0.01% 1564
2013
Q4
$2.17M Sell
442,000
-80,000
-15% -$452K ﹤0.01% 1525
2013
Q3
$2.88M Buy
522,000
+216,000
+71% +$1.36M ﹤0.01% 1489
2013
Q2
$2.23M Buy
+306,000
New +$2.6M ﹤0.01% 1513

Other funds holding IMI

T. Rowe Price Associates's IMI Position: Q1 2019 in Review

T. Rowe Price Associates sold out of Intermolecular, Inc. (IMI) in Q1 2019, closing a stake of 156,015 shares — an estimated $158K sold.

T. Rowe Price Associates first reported a position in IMI in Q2 2013 and held it in 20 quarters. The position peaked at $2.88M in Q3 2013. 28 funds tracked by Wall St. Rank hold IMI as of Q1 2019.

  • T. Rowe Price Associates reported no remaining Intermolecular, Inc. position as of Q1 2019 after selling out during the quarter.
  • T. Rowe Price Associates sold 156,015 Intermolecular, Inc. shares in Q1 2019, an estimated $158K.
  • T. Rowe Price Associates first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 20 quarters.
  • T. Rowe Price Associates's Intermolecular, Inc. position peaked at $2.88M in Q3 2013.
  • 28 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q1 2019.

Based on T. Rowe Price Associates's 13F filing for Q1 2019, filed 15 May 2019.